Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON37774
NL-OMON37774
Completed
Not Applicable

Early detection and prediction of cardiotoxicity in breast cancer patients treated with chemotherapy using the high sensitivity troponin T assay. - Use of high sensitivity troponin t to detect and predict cardiotoxicity

Maxima Medisch Centrum0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscardiotoxicityheart failure1001928010006291

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cardiotoxicity
Sponsor
Maxima Medisch Centrum
Enrollment
40
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • •\-Female breast cancer patients
  • •\-Age between 30\-60 years
  • •\-18\-weeks of chemotherapy\-treatment, adjuvant or neo\-adjuvant
  • •\-Chemotherapy may include: (AC) adriamycin/cyclophosphamide, (FEC) fluorouracil/epiribicin/cyclophosphamide, (TAC) taxotere/ adriamycin/cyclophosphamide
  • •\-Ejection fraction \> 50%

Exclusion Criteria

  • •\-Ejection fraction \<50%
  • •\-previous signs of cardiovascular disease
  • •\-kidney dysfunction (eGFR \<60 ml/min/1,73m^2\).
  • •\-previous treatment with anthracyclines

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
To study the early changes in function of the heart in breast cancer patients undergoing chemotherapy using ultrasound scan of the heart
CTRI/2023/06/053695Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal
Recruiting
Not Applicable
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer ChemotherapyBreast Cancer
NCT06282796First Hospital of China Medical University600
Suspended
Not Applicable
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer PatientsBreast Cancer
NCT02062983National Guard Health Affairs50
Completed
Not Applicable
Biomarker evaluation as the cardiotoxic evaluation index in the molecular target drug for breast cancer treatmentHER2-positive breast cancer
JPRN-UMIN000020690Division of Breast Oncology,Cancer Institute Hospital of Japanese Foundation for Cancer Research113
Completed
Not Applicable
Early detection of cardiovascular risk factors after pregnancy complicated by hypertensive disorders or spontaneous preterm birthcardiovascular disease after hypertensive disorders in pregnancy or after spontaneous preterm birth100192801002690810057166
NL-OMON45089Vrije Universiteit Medisch Centrum687